Fingerprint
Dive into the research topics of 'Outcomes in 1096 patients with severe thrombotic thrombocytopenic purpura before the Caplacizumab era'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Outcomes in 1096 patients with severe thrombotic thrombocytopenic purpura before the Caplacizumab era
Andry Van De Louw, Eric Mariotte, Michael Darmon, Austin Cohrs, Douglas Leslie, Elie Azoulay
- Department of Medicine
- Division of Pulmonary, Allergy and Critical Care Medicine
- Penn State Cancer Institute
- Cancer Institute, Cancer Control
- Department of Public Health Sciences
- Division of Health Services and Behavioral Research
- Department of Psychiatry and Behavioral Health
- Center for Cannabis and Natural Product Pharmaceuticals (CCNPP)
Research output: Contribution to journal › Article › peer-review
18
Scopus
citations